FDA Inspection 1076589 — Lotus Laboratories Pvt. Ltd.

Lotus Laboratories Pvt. Ltd. — FEI 3004918131

The FDA completed an inspection of Lotus Laboratories Pvt. Ltd. on November 23, 2018 in Bangalore. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
November 23, 2018
Fiscal Year
2019
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Bangalore (India)

Additional Details

Bioanalytical BA/BE